Mangione Plea Talks Collapsed Before Monday's Federal Hearing, as Defense Strategy Remains Unclear

Since Mangione's December 2024 arrest following the targeted killing of UnitedHealthcare CEO Brian Thompson, 50, his parallel state and federal cases have moved toward trial dates on a collision course. This week added a new layer of uncertainty.

Defense attorneys for Mangione and federal prosecutors in the Southern District of New York held preliminary plea discussions ahead of Monday's pretrial hearing, but talks broke down before any agreement was reached, according to two sources familiar with the matter cited by CBS News. How close the two sides came, and whether negotiations could resume, is unknown. A spokesman for the U.S. Attorney's office declined to comment to CBS News. Manhattan District Attorney Alvin Bragg also declined comment.

The Monday hearing in Manhattan federal court, before U.S. District Judge Margaret Garnett, is expected to address trial scheduling. The federal trial is currently set for October, with prospective jurors scheduled to begin filling out questionnaires September 11. That date collides almost directly with the state trial, where jury selection is set to begin September 8 under Judge Gregory Carro. Judge Garnett has signaled openness to pushing the federal trial to early 2027, according to the New York Post.

The Defense Whiplash

The scheduling tangle is just part of the picture. The more striking development came in the state case earlier this month.

Judge Carro announced he would be unsealing the record relating to Mangione's CPL 250.10 notice — a formal declaration that the defense was "proceeding with an affirmative psychiatric defense … extreme emotional disturbance [EED] at the time and place of the occurrence." Under New York law, that filing triggers mandatory disclosure: the defense must turn over expert reports, the defendant's diagnosis, and any records experts relied on.

Mangione's lead attorney, Karen Friedman Agnifilo, had previously argued for sealing those proceedings specifically because, as she told Judge Carro directly: "If a defendant goes with an EED defense, they're essentially admitting publicly that they committed this crime." She warned that unsealing could poison the jury pool in both the state and federal cases, according to transcripts reported by The Guardian.

Then, on June 18, transcripts from the earlier sealed proceeding were unsealed — and at approximately the same time, a letter from Mangione's defense was made public stating "the defense respectfully withdraws CPL 250.10 notice at this time." The defense withdrew the psychiatric defense notice entirely within roughly 24 hours of that transcript becoming public.

When NBC News New York first reported the plea negotiations on Thursday, June 26, Agnifilo's office pushed back hard. "This information attributed to 'anonymous sources' is part of a troubling, deliberate pattern by prosecutors and law enforcement to prejudice Luigi, manipulate public opinion, and violate his constitutional right to a fair trial and impartial jury," Agnifilo said in a statement to CBS News.

Pre-trial leaks about plea negotiations, whether accurate or not, can complicate settlement talks, inflame public opinion, and make it harder for either side to negotiate without political pressure. The defense's frustration is understandable on its face.

That said, CBS News legal analyst Jessica Levinson and former Palm Beach County State Attorney Dave Aronberg both noted that pre-trial plea discussions are entirely routine. "They're going to have a conversation about whether or not they will do a deal. It is not at all uncommon," Levinson told CBS News. Aronberg pointed to Bryan Kohberger, who pleaded guilty last July to four murders as part of a deal that took the death penalty off the table, as a recent example of how late negotiations can run.

What's Actually Left of the Federal Case

One underreported detail: Mangione is no longer charged with murder in the federal case. Judge Garnett tossed the death-penalty-eligible murder charges, and what remains is a federal stalking charge, according to the New York Post. The Trump Justice Department had moved in with the federal case — originally carrying death penalty exposure — after lobbying from health industry leaders following Thompson's killing, the Post reported.

Mangione still faces life in prison in the state case under Manhattan DA Bragg, where the murder charges are intact.

The 28-year-old has pleaded not guilty in both cases.

The Open Question

With the psychiatric defense withdrawn, plea talks dead for now, and two trial dates still on a collision path, Mangione's actual defense strategy at trial remains unclear. The EED withdrawal is particularly significant. Legal experts are divided on what it means: adjunct professor and former prosecutor Gary Galperin said he believes Mangione's team will not pursue a psychiatric defense at all, cautioning observers not to read too much into the defense's use of the phrase "at this time." But veteran defense attorney Ron Kuby, who is not on Mangione's team, noted that withdrawing a CPL 250.10 notice is not the same as abandoning a psychiatric defense entirely — a defendant can still mount an EED defense based on the prosecution's evidence, or through the defendant's own testimony, without the disclosure obligations the notice triggers. Whether the withdrawal is a tactical delay or a permanent strategic pivot is something even the court watchers who have followed this case closely cannot answer yet.